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The ESCRTs play multiple roles within the cell, including degradation of ubiquitinated membrane proteins by
sorting them into multivesicular bodies (MVBs). Two recent studies provide structural and functional insights
into how the newly identified ESCRT-I component UBAP1 dedicates ESCRT-I function for sorting ubiquiti-
nated proteins at the MVB (Agromayor et al., 2012 [this issue of Structure]; Stefani et al., 2011).The endosomal sorting complexes
required for transport (ESCRTs) were first
discovered in yeast as important for en-
dosomal trafficking and sorting of
proteins to the vacuole. Several studies
showed the critical role these complexes
play in the biogenesis of multivesicular
bodies (Shields and Piper, 2011). Here,
the limiting membrane of endosomes
invaginates to produce intralumenal vesi-
cles (ILVs) that incorporate membrane
proteins, which are eventually delivered
and degraded in the lumen of the vacuole.
Membrane proteins are designated for
multivesicular body (MVB) sorting upon
ligation to ubiquitin (Ub). Ubiquitinated
membrane proteins are then recognized
by a series of ESCRTs, which house
multiple Ub-binding domains and orches-
trate the formation and completion of
ILVs. Collectively, ESCRTs comprise
four evolutionary conserved multimeric
complexes (ESCRT-0,-I, -II, and -III) that
interact with each other in addition to
cofactors such as AAA ATPase Vps4,
which help ESCRT disassembly and recy-
cling, and the accessory protein Bro1,
which binds ESCRT-III and recruits the
deubiquitinating enzyme Doa4p to re-
move Ub from cargo in the last stages of
sorting.
All of the ESCRTs, together with many
ESCRT-associated proteins, are critical
for MVB sorting in yeast, and the lack of
any of these components largely yields
the same set of endosomal defects. The
MVB sorting function and basic architec-
ture of ESCRTs are conserved between
yeast and humans. However, in the latter,
ESCRTs serve additional roles that
involve membrane deformation and scis-
sion or recognition of Ub. These functions
encompass roles in signal transduction,
the last step of cytokinesis, as well as
activity of transcription factors. In addi-tion, budding and release of a variety of
viruses from the plasma membrane
involves viral hijacking components of
the ESCRT machinery (Babst et al.,
2011; Caballe and Martin-Serrano, 2011;
Wegner et al., 2011). How the ESCRTs
can distinguish themselves to perform
these distinct functions remains an impor-
tant question. Part of the answer lies in the
use of or reliance on a subset of ESCRT
components for particular jobs. For in-
stance, while deletion of yeast ESCRT-II
is clearly required for yeast MVB sorting,
its absence does not affect viral budding
in mammalian cells and only moderately
perturbs MVB sorting in animal cells.
Also, while yeast Ist2 regulates ESCRT-
dependent MVB biogenesis, its most
prominent role in mammalian cells is to
control cytokinesis.
Two recent studies now identify a new
subunit of mammalian ESCRT-I, Ub asso-
ciated protein 1 (UBAP1), which appears
to tailor this ESCRT for its function in sort-
ing ubiquitinated proteins into MVBs
(Figure 1). ESCRT-I is a heterotetramer
of Vps23/TSG101, Vps28, Vps37, and
MVB12. ESCRT-I directly binds ESCRT-0,
a dimeric protein complex comprised in
part by Hrs/Vps27 that has multiple Ub-
binding domains (UBDs) thought to act
in the initial stages of binding and sorting
ubiquitinatedmembrane proteins (Shields
and Piper, 2011). The other end of
ESCRT-I binds components in ESCRT-II
and ESCRT-III, thus serving as a con-
nector that can convey ubiquitinated
cargo into nascent ILVs that are ultimately
completed by the action of ESCRT-III.
Since ESCRT-I stands at a critical nexus
for sorting ubiquitinated MVB cargo
proteins, it makes sense that ESCRT-I
would rely on its ability to bind Ub to
complete its tasks. Yeast ESCRT-I
contains two UBDs, one in the N-terminalStructure 20, March 7, 2012Ub E2 variant (UEV) domain of Vps23 and
one in the C-terminal portion of Mvb12,
which together partially contribute to the
ability of ESCRT-I to bind and sort Ub-
cargo proteins into MVBs. Mammalian
ESCRT-I is somewhat different. The UEV
domain of mVps23/TSG101 binds Ub,
but this low affinity UBD has not yet
been found to be critical for MVB sorting.
Homologs for Mvb12, namely Mvb12A
and Mvb12B, have been found. Mvb12A
appears to have Ub binding activity as
well, but mammalian Mvb12s contribute
to ESCRT-dependent virus budding from
the plasma membrane and have not
been found to be critical for MVB sorting
(Morita et al., 2007; Tsunematsu et al.,
2010). Recent findings now show that
UBAP1, the third ‘‘Mvb12-like’’ ESCRT-I
subunit, is the one that endows ESCRT-I
with the power to sort Ub-cargo into
MVBs (Stefani et al., 2011; Agromayor
et al., 2012 [this issue of Structure]).
The study by Agromayor et al. (2012) (in
this issue of Structure) reveals that
UBAP1 is a biochemically stable subunit
of mammalian heterotetrameric ESCRT-I
complex. UBAP1 uses its N-terminal
UBAP1-MVB12-associated (UMA) do-
main, as previously suggested from bio-
informatics studies (de Souza and
Aravind, 2010), to bind the central stalk
region of ESCRT-I. The C-terminal region
of UBAP1 binds Ub via three concatemer-
ized Ub-associated (UBA) domains,
which comprise the novel solenoid of
overlapping UBAs (SOUBA) domain.
UBAs comprise a large class of UBDs
and are present in a wide variety of
proteins with diverse functions (Dikic
et al., 2009). UBAs are small three-helix
bundles that use a conserved hydro-
phobic surface to interact with key hydro-
phobic residues on the surface of Ub.
Agromayor et al. (2012) solved a 1.65 A˚ª2012 Elsevier Ltd All rights reserved 383
Figure 1. UBAP-1 Focuses ESCRT-I on the Task of MVB sorting
(Left) Collectively, ESCRTs provide several functions in the cell, including catalyzing the last step in cytokinesis, completing the budding of a variety of enveloped
viruses from the cell surface, and regulating transcription factors. ESCRTs also sort ubiquitinated membrane proteins into intralumenal vesicles that bud from the
limiting membrane of endosomes.
(Right) Heterotetrameric ESCRT-I composed of UBAP1 contains several Ub-binding domains, including the novel SOUBA domain within UBAP1 and the UEV
domain of TSG101. This allows ESCRT-I to interact readily with ubiquitinated membrane protein cargoes. Interaction sites on ESCRT-I also position this complex
between upstream Ub-sorting receptors, such as ESCRT-0, and downstream ESCRTs that complete ILV formation.
Structure
Previewscrystal structure of the UBAP1 SOUBA,
revealing seven a helices overlapping as
rigid solenoid-like structures that provide
the basis for the SOUBA moniker: sole-
noid of overlapping UBAs. NMR chemical
shift perturbation titration experiments
with 15N-labeled Ub and SOUBA
confirmed interaction with the I44 V70
hydrophobic patch of Ub, whichmediates
the vast majority of interactions Ub has
with its binding partners (Dikic et al.,
2009). NMR experiments also revealed
that all three of the UBA subdomains
within SOUBA bind Ub using a G-F/Y
motif as found for other UBAs. These
data combined with constraints from
paramagnetic relaxation experiments
using spin-labeled Ub allowed the authors
to build a compelling model for how
SOUBA binds Ub.
ITC experiments showed that SOUBA
binds Ubwith an affinity of70 mM, which
is higher than the majority of UBDs (which
typically bind in the hundreds of mM
range) and is almost 10-fold higher than
the affinity of the UEV domain of
TSG101 ESCRT-I subunit. In addition,
SOUBA had comparable ability to bind
mono-Ub or K48- and K63-linked diubi-
quitin chains. This makes UBAP1 nicely
equipped to mediate ESCRT-I-depen-
dent sorting of Ub-cargo into MVBs,
a process that can recognize both mono-
ubiquitinated cargo as well as cargo384 Structure 20, March 7, 2012 ª2012 Elsevmodified by short K63-linked chains
(Shields and Piper, 2011). Importantly,
siRNA depletion of UBAP1 resulted in
the accumulation of ubiquitinated
proteins on endosomes and impaired
the lysosomal degradation of tetherin, a
membrane protein that undergoes Ub-
dependent MVB sorting during HIV infec-
tion (Agromayor et al., 2012; Stefani et al.,
2011). Reducing UBAP1 also caused en-
dosomal swelling and diminished Ub-
dependent MVB sorting and lysosomal
degradation of EGFR. In addition, mutant
UBAP1 with inactivating point mutations
in two of its three UBA subdomains, which
diminished its capacity for Ub-binding,
did not restore MVB sorting of Ub-cargo
to UBAP1-depleted cells (Stefani et al.,
2011). Although depletion of UBAP1 had
profound effects on MVB sorting, its loss
did not impact cytokinesis or viral
budding. Thus, the ESCRT-I MVB sorting
function requires the high affinity Ub-
binding activity that UBAP1 can provide,
whereas other ESCRT-I functions do not.
Theoretically, human ESCRT-I can
assemble with one of four Vps37 isoforms
and one of three UMA-containing iso-
forms (Mvb12-A, Mvb12-B, and UBAP1).
Although Stefani et al. (2011) suggest
that UBAP1 favors co-assembly with
Vps37A, there may be upwards of 12
different ESCRT-I complexes, not count-
ing variations from alternative transcripts.ier Ltd All rights reservedThis provides an intriguingly high capacity
to tailor ESCRT-I for particular functions.
One aspect that remains to be fully
explored is the extent to which different
dedicated ESCRT-I complexes can differ-
entially interact with upstream and down-
stream components. At least one such
component is HD-PTP, a protein related
to another ESCRT-associated protein
Alix. HD-PTP binds directly to UBAP1
and can act as a cargo receptor, for at
least artificial cargo (Doyotte et al., 2008;
Stefani et al., 2011). One plausible model
is that HD-PTP works as an alternate
ESCRT-0 and would be involved in the
initial recognition of additional cargo that
could be brought to ESCRT-I (Shields
and Piper, 2011). This first peak at
UBAP1 hints at many more ways that
the ESCRTs can be functionally tailored
and dressed up for different cellular jobs.REFERENCES
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Despite its physiological importance, no part of human leptin receptor (ObR) has been structurally char-
acterized before. In this issue of Structure, Carpenter et al. report the crystal structure of the leptin-
binding domain of human ObR in complex with the Fab fragment of an ObR-blocking monoclonal
antibody (9F8 mAb).The discovery of leptin (ob gene), an
adipose tissue-derived cytokine-like hor-
mone, led the scientific community to
focus attention on its role as an anorexic
hormone involved in the negative re-
gulation of food intake (Friedman and
Halaas, 1998). Leptin is now known to
participate in a wide range of biological
functions that include—in addition to its
function as an adipostat—glucose meta-
bolism, CD4+ T lymphocyte proliferation,
cytokine secretion, phagocytosis, regula-
tion of the hypothalamic-pituitary-adrenal
axis, reproduction, angiogenesis and car-
diovascular pathology, bone formation,
and apoptosis (La Cava and Matarese,
2004) (Figure 1). It is now well docu-
mented that leptin acts like a cytokine
hormone with many pleiotropic effects,
as well as that many effects of leptin are
acquired through systemic and peripheral
activities.
Leptin is a helical-cytokine structurally
similarly to interleukin (IL)-6, IL-12, and
IL-15. Its receptor (ObR) belongs to the
class I cytokine receptors, which includes
gp-130, the common signal transducing
component for the IL-6-related family of
cytokines (Tartaglia, 1997). Leptin is ex-pressed mostly in the adipose tissue and
at lower levels in the muscle, stomach,
and placenta (Friedman and Halaas,
1998). More recently, it has also been
shown that leptin can be expressed by
activated inflammatory T helper 1 lym-
phocytes in experimental autoimmune
encephalomyelitis, an animal model of
multiple sclerosis (Sanna et al., 2003).
Accordingly, ObR can be found not only
in the hypothalamus and adipose tis-
sue, but also on immune cells such as
T lymphocytes and monocytes, endothe-
lial cells, and CD34+ bone marrow precur-
sors (Figure 1).
To date, despite the extensive genetic
and cellular analysis, structural studies
of ObR were missing. In this issue
of Structure, Carpenter et al. (2012)
elegantly characterize the crystal struc-
ture of the Fab fragment of an anti-hObR
monoclonal antibody (9F8 mAb) (Fazeli
et al., 2006), both in its uncomplexed state
and bound to the leptin-binding domain
(LBD) of human ObR. Strikingly, 9F8
mAb is the only anti-human ObR neutral-
izing mAb described to date. The authors
crystallized 9F8 mAb in its uncomplexed
state and solved its crystal structure ata 2.3 A˚ resolution. They further solved
the structure of 9F8 Fab complexed with
LBD at 1.95 A˚ resolution using Fab-medi-
ated crystallization. Their study describes
the structure of the LBD-9F8 Fab complex
and the changes induced in 9F8 Fab by
LBD binding. The authors also con-
structed and characterized a molecular
docking model of the leptin-LBD com-
plex, which revealed how 9F8 Fab
can antagonize leptin signaling. Overall,
these findings provide new insight into
the mechanism of leptin binding to LBD
and the mechanism of 9F8 antagonism
of leptin signaling.
To date, the crystallization of isolated
LBD or a leptin-LBD complex has proven
difficult. Although there are numerous
possible reasons for this, a major factor
was likely the presence of several flexible
loops within LBD, which limit the surface
area amenable to crystal contact for-
mation. Fab-mediated crystallization is a
powerful tool to improve crystallization
of challenging proteins by stabilizing
dynamic regions, thus increasing the
hydrophilic surface area available for
crystal lattice formation and masking
unfavorable regions of the protein. Here,ª2012 Elsevier Ltd All rights reserved 385
